<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02595190</url>
  </required_header>
  <id_info>
    <org_study_id>No.29SROSWH-2015</org_study_id>
    <nct_id>NCT02595190</nct_id>
  </id_info>
  <brief_title>Treatment of the Symptomatic Sacral Perineurial Cysts</brief_title>
  <acronym>TSSPC</acronym>
  <official_title>A Randomized Controlled Trial to Compare the Efficacy of Medicine Conservative Treatment and Surgical Treatment for Symptomatic Sacral Perineurial Cysts (Tarlov Cysts) and the Applied Value of Resting State Functional Magnetic Resonance Imaging (rfMRI).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southwest Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southwest Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are very few data and analysis in the literature regarding the symptomatic sacral
      perineurial cysts. Most studies are case reports or small retrospective sample, which rarely
      more than 20 cases. There is no an consensus on the choice of treatment (medicine
      conservative treatment and surgical treatment) for symptomatic sacral perineurial cysts.Our
      aim, therefore, is to compare the efficacy of medicine conservative treatment and surgical
      treatment for symptomatic sacral perineurial cysts by a randomized controlled trial.
      Meanwhile, resting-state functional magnetic resonance imaging is used to detect the changes
      at pain related brain areas, which will be develop an objective method to evaluate the
      clinical curative effect of the two treatment options.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analog scale(VAS)</measure>
    <time_frame>3year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Structure and Function connection change(e.g., increase or decrease the thickness of the cortex, or gray matter;function connection increase or decrease) at somatosensory area</measure>
    <time_frame>1year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Modify Japanese orthopedic association low back pain score (M-JOA)</measure>
    <time_frame>3year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index score (DOI)</measure>
    <time_frame>3year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MacNab curative effect evaluation</measure>
    <time_frame>3year</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Size of the cyst</measure>
    <time_frame>3year</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Number of the cyst</measure>
    <time_frame>3year</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Urine dynamics change(e.g., urinary flow rate)</measure>
    <time_frame>3year</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Perianal electromyography change</measure>
    <time_frame>3year</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>surgery group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sacral canal cyst microscopic tamponade treatment; resting state functional magnetic resonance imaging (rfMRI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>drug group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>gabapentin + tramadol tablets; resting state functional magnetic resonance imaging (rfMRI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>resting state functional magnetic resonance imaging (rfMRI)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sacral canal cyst microscopic tamponade</intervention_name>
    <description>sacral canal cyst microscopic tamponade treatment</description>
    <arm_group_label>surgery group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>gabapentin + tramadol</intervention_name>
    <description>dose rangeï¼šgabapentin 400-1200mg tid, tramadol 100-200mg bid</description>
    <arm_group_label>drug group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>resting state functional magnetic resonance imaging (rfMRI)</intervention_name>
    <description>First time:2 days before Surgery or Drug use; Second time:3 months after Surgery or Drug use; Third time:1 year after Surgery or Drug use</description>
    <arm_group_label>surgery group</arm_group_label>
    <arm_group_label>drug group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. Diagnosed with symptomatic sacral perineurial cysts(e.g., lumbosacral or perineal
             pain, fecal or urinary functions change, sexual function change, lower limb radiation
             pain, muscle abate, paresthesia, etc)

          -  2. Visual analog scale more than or equal to 4

          -  3. Signed the informed consent

          -  4. Years, range 18-60

          -  5. Self-rating anxiety scale (SAS) and self-rating depression scale (SDS) scores &lt; 50

          -  6. No Congenital,Mental and other Nervous system diseases

          -  7. No Serious Cardiac,Pulmonary,Hepatic and Nephritic disease

          -  8. No history of drug allergy

          -  9. No pain(including dysmenorrhea) or drug use (e.g., antipyretics,sleeping pills)
             within the last month

          -  10. MRI finding of sacral perineurial cysts, but without any clinical symptoms,
             included in the negative control group

          -  11. MRI finding healthy volunteers don't have sacral perineurial cysts, included in
             the negative control groupblank control group

        Exclusion Criteria:

          -  1. Patients with lumbar common diseases(e.g., Lumbar disc, Lumbar spinal stenosis,
             Lumbar slippage, etc)

          -  2. Researchers think that Patients with disease may be interference results(e.g.,
             Spinal deformity, spine fracture, ankylosing spondylitis, spinal tuberculosis and
             spinal infection, spinal tumor, pelvic inflammatory disease and other disease of
             department of gynaecology, etc)

          -  3. Patients with other nervous system diseases(e.g., cerebral tumor, neurinoma,
             trigeminal neuralgia,etc)

          -  4. Patients with Magnetic resonance imaging contraindication ,including claustrophobic
             syndrome patients

          -  5. Patients with recent (less than 3 years) use chemical drugs or have obvious
             psychological problems

          -  6. In the past 2 months involved in other drugs or devices clinical trials
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>jiangkai lin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neurosurgery department of Southwest Hospital,China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>jiangkai lin, PhD</last_name>
    <phone>+86-13508350708</phone>
    <email>jklin@tmmu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>weihua chu, PhD</last_name>
    <phone>+86-13657648800</phone>
    <email>Weihua9871@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Southwest Hospital</name>
      <address>
        <city>Chongqing</city>
        <zip>023</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jiangkai lin, PhD</last_name>
      <phone>13508350708</phone>
      <email>jklin@tmmu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2015</study_first_submitted>
  <study_first_submitted_qc>November 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 3, 2015</study_first_posted>
  <last_update_submitted>November 1, 2015</last_update_submitted>
  <last_update_submitted_qc>November 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southwest Hospital, China</investigator_affiliation>
    <investigator_full_name>Jiangkai Lin</investigator_full_name>
    <investigator_title>Vice chief of Neurosurgery Department</investigator_title>
  </responsible_party>
  <keyword>Sacral perineurial cysts(Tarlov Cysts)</keyword>
  <keyword>Resting state functional magnetic resonance imaging (rfMRI)</keyword>
  <keyword>VAS</keyword>
  <keyword>Medicine conservative treatment</keyword>
  <keyword>Surgical treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tarlov Cysts</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

